But raising tariffs on prescription drugs could carry additional risks for the new administration, as well as for drug manufacturers and insurance companies.
How much U.S. patients feel the effects of tariffs depends on whether pharmaceutical companies seek to pass the costs on to others in the medical system. If they do, a key question for many consumers is whether insurance companies would seek to offset higher prices through larger co-payments, higher insurance premiums or more restrictive coverage plans.
“If the tariff cost can be passed on to consumers, the pharmaceutical companies will happily do that,” said Brad Setser, a senior fellow at the nonpartisan Council on Foreign Relations. But if insurers balk at paying higher prices as a result of tariffs, the drugmakers could have to absorb the costs themselves, largely undoing tax advantages they’ve reaped by moving their profits abroad, he said.
Disclaimer
The information contained in South Florida Reporter is for general information purposes only.
The South Florida Reporter assumes no responsibility for errors or omissions in the contents of the Service.
In no event shall the South Florida Reporter be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of the Service or the contents of the Service. The Company reserves the right to make additions, deletions, or modifications to the contents of the Service at any time without prior notice.
The Company does not warrant that the Service is free of viruses or other harmful components
